Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Lax Enforcement Spurs Suits Over Insurers' 'Ghost' Networks No Photo Available

Hannah Albarazi

More patients are alleging insurers "ghost networks" — directories full of unreachable providers — deny them access to mental health c... (more story)

Vax Critic Atty Wants To 'Depoliticize' Shots No Photo Available

Yeji Jesse Lee

Attorney Aaron Siri, who specializes in vaccine cases and has close ties to Health and Human Services Secretary Robert F. Kennedy Jr.,... (more story)

FCA Bar Eager To Scrutinize 11th Circ. Qui Tam Debate No Photo Available

Dan McKay

An Eleventh Circuit panel this week will help decide the fate of the qui tam provisions of the False Claims Act. The FCA bar is watchi... (more story)